DV
Dividend Vision

SOPH — Sophia Genetics SA

Sophia Genetics SA (SOPH)

Total return is -55.3% over the past 5.1 years, 144.1 points behind SPY at 88.8%. Its deepest 1-year drawdown was 25.7%.

This is a single-stock equity fund that tracks Sophia Genetics SA, a Switzerland-based provider of AI-driven diagnostic intelligence solutions for genomic data analysis. The fund does not currently pay distributions, making it a non-dividend-paying equity holding with no published expense ratio or distribution frequency data available. The fund appeals primarily to investors seeking exposure to the genomic sequencing and AI diagnostics sector rather than to income-focused investors.

SOPH key facts

Asset type
Stock
Asset class
Equity
Inception date
07/23/2021
Last close
$7.50
Market cap
$531,057,024
Average volume
193279.0
Beta
0.958
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.28